
    
      Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or
      hepatitis C virus infection will be included in the study to measure plasma cytokines levels,
      peripheral blood mononuclear cells cytokine release and liver IL-6R compounds mRNA levels.
    
  